Señales en vivo de NAVA.OL | Maximiza tus Ganancias con Getagraph.com

VENDER 75 min ago

@ Kr.33.50

Emitido: 7 may 2024 @ 05:03

Retorno: -0.30%

Señal anterior: may 6 - 08:27

Señal anterior: Comprar

Retorno: 0.30 %

Live Chart Being Loaded With Signals

Commentary (7 may 2024 @ 06:00):
Our systems believe the stock currently is overvalued by 1.22% compare to its pairs and should correct downwards.

Stats
Volumen de hoy	3 030.00
Volumen promedio	86 862.00
Capitalización de mercado	564.93M
EPS	Kr.0.390 ( 2023-11-01 )
Próxima fecha de ganancias	( Kr.0 ) 2024-05-31
Last Dividend	Kr.0.998 ( 2010-04-13 )
Next Dividend	Kr.0 ( N/A )
P/E	28.31
ATR14	Kr.0.684 (2.05%)

Correlación (AI algo v.1.1b): Overvalued: -1.22% Kr.32.99 paired level. (El Algoritmo Rastrea Los Cambios De Las Acciones Más Correlacionadas En Tiempo Real Y Proporciona Una Actualización Instantánea)

Volumen Correlación

Largo: 0.32 (neutral)

Corto: 1.00 (very strong)

Signal:(97) Expect same movement, but be aware

Navamedic ASA Correlación

10 Correlaciones Más Positivas
NORSE.OL	0.895
SMOP.OL	0.871
NTEL.OL	0.871
TOM.OL	0.868
ENDUR.OL	0.839
XXL.OL	0.838
KIT.OL	0.832
SNI.OL	0.826
BORR.OL	0.815
AYFIE.OL	0.813

10 Correlaciones Más Negativas
AKBM.OL	-0.895
ODL.OL	-0.895
SCATC.OL	-0.893
SBX.OL	-0.87
OKEA.OL	-0.858
VOLUE.OL	-0.857
PHO.OL	-0.854
FRO.OL	-0.852
TRVX.OL	-0.846
XPLRA.OL	-0.842

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Navamedic ASA Correlación - Moneda/Commodity

0.34
( neutral )

0.39
( neutral )

0.00
( neutral )

0.36
( neutral )

0.00
( neutral )

-0.14
( neutral )

Navamedic ASA Finanzas

Annual	2023
Ingresos:	Kr.512.00M
Beneficio Bruto:	Kr.123.46M (24.11 %)
EPS:	Kr.0.190

FY	2023
Ingresos:	Kr.512.00M
Beneficio Bruto:	Kr.123.46M (24.11 %)
EPS:	Kr.0.190

FY	2022
Ingresos:	Kr.382.14M
Beneficio Bruto:	Kr.163.52M (42.79 %)
EPS:	Kr.1.750

FY	2021
Ingresos:	Kr.278.44M
Beneficio Bruto:	Kr.111.74M (40.13 %)
EPS:	Kr.0.00774

Financial Reports:

No articles found.

Navamedic ASA Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
Kr.0 (N/A)	Kr.0 (N/A)	Kr.0 (N/A)	Kr.0 (N/A)	Kr.0 (N/A)	Kr.0 (N/A)	Kr.0 (N/A)	Kr.0 (N/A)	Kr.0 (N/A)	Kr.0 (N/A)

Navamedic ASA Dividend Information - No Dividend Player

Dividend Sustainability Score: 2.56 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	Kr.0.998	2010-04-13
Last Dividend	Kr.0.998	2010-04-13
Next Dividend	Kr.0	N/A
Payout Date	2010-04-27
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	Kr.0.998	--
Avg. Dividend % Per Year	0.00%	--
Score	0.07	--
Div. Sustainability Score	2.56
Div.Growth Potential Score	0
Div. Directional Score	0.187	--

Next Divdend (Est)
(2024-05-07)

Kr.0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.07

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2010	Kr.0.998	17.80%
2011	Kr.0	0.00%
2012	Kr.0	0.00%
2013	Kr.0	0.00%
2014	Kr.0	0.00%
2015	Kr.0	0.00%
2016	Kr.0	0.00%
2017	Kr.0	0.00%
2018	Kr.0	0.00%
2019	Kr.0	0.00%
2020	Kr.0	0.00%
2021	Kr.0	0.00%
2022	Kr.0	0.00%
2023	Kr.0	0.00%
2024	Kr.0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for OSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
ALNG.OL	Dividend King	2023-11-27	Quarterly	2	6.60%	7.04
OKEA.OL	Dividend Knight	2023-12-01	Quarterly	3	5.65%	6.86
SALM.OL	Dividend Knight	2023-06-09	Annually	17	2.80%	4.97
BWLPG.OL	Dividend Knight	2023-11-17	Quarterly	11	1.68%	4.46
BWO.OL	Dividend Knight	2023-11-20	Quarterly	14	0.87%	3.96
ATEA.OL	Dividend Knight	2023-11-20	Annually	16	2.97%	3.45
HAFNI.OL	Dividend Knight	2023-11-23	Semi-Annually	5	1.18%	3.31
AKER.OL	Dividend Knight	2023-11-07	Semi-Annually	20	2.99%	3.13
AUSS.OL	Dividend Knight	2023-05-26	Annually	17	3.23%	2.93
GSF.OL	Dividend Knight	2023-06-28	Annually	15	3.81%	2.67

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0224	1.500	-0.448	-0.672	[0 - 0.5]
returnOnAssetsTTM	-0.0213	1.200	-0.711	-0.853	[0 - 0.3]
returnOnEquityTTM	-0.0521	1.500	-1.690	-2.54	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.378	0.800	8.11	6.49	[1 - 3]
quickRatioTTM	0.439	0.800	-2.12	-1.698	[0.8 - 2.5]
cashRatioTTM	0.146	1.500	-0.298	-0.447	[0.2 - 2]
debtRatioTTM	0.275	-1.500	5.41	-8.12	[0 - 0.6]
interestCoverageTTM	1.577	1.000	-0.527	-0.527	[3 - 30]
operatingCashFlowPerShareTTM	-0.622	2.00	-0.207	-0.415	[0 - 30]
freeCashFlowPerShareTTM	-0.740	2.00	-0.370	-0.740	[0 - 20]
debtEquityRatioTTM	0.653	-1.500	7.39	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.243	1.000	9.29	9.29	[0.2 - 0.8]
operatingProfitMarginTTM	0.0227	1.000	-1.546	-1.546	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.0727	1.000	-1.515	-1.515	[0.2 - 2]
assetTurnoverTTM	0.952	0.800	6.99	5.59	[0.5 - 2]
Total Score				2.56

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-50.70	1.000	-5.22	0	[1 - 100]
returnOnEquityTTM	-0.0521	2.50	-1.087	-2.54	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.740	2.00	-0.247	-0.740	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.622	2.00	-0.207	-0.415	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.822	1.500	-8.82	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0210	1.000	-3.03	0	[0.1 - 0.5]
Total Score				-2.19

Navamedic ASA

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, women's health, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.